Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6
Closed -$1K 351
2022
Q3
$1K Hold
6
﹤0.01% 289
2022
Q2
$1K Hold
6
﹤0.01% 307
2022
Q1
$1K Hold
6
﹤0.01% 321
2021
Q4
$1K Hold
6
﹤0.01% 309
2021
Q3
$1K Sell
6
-8
-57% -$1.66K ﹤0.01% 306
2021
Q2
$3K Buy
14
+3
+27% +$787 ﹤0.01% 225
2021
Q1
$3K Sell
11
-2
-15% -$564 ﹤0.01% 237
2020
Q4
$4K Hold
13
﹤0.01% 202
2020
Q3
$3K Buy
+13
New +$2.96K ﹤0.01% 204

Other funds holding AMED

AUA Capital Management's AMED Position: Q4 2022 in Review

AUA Capital Management sold out of Amedisys (AMED) in Q4 2022, closing a stake of 6 shares — an estimated $1K sold.

AUA Capital Management first reported a position in AMED in Q3 2020 and held it in 9 quarters. The position peaked at $4K in Q4 2020. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

  • AUA Capital Management reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
  • AUA Capital Management sold 6 Amedisys shares in Q4 2022, an estimated $1K.
  • AUA Capital Management first reported a position in Amedisys in Q3 2020 and held it in 9 quarters.
  • AUA Capital Management's Amedisys position peaked at $4K in Q4 2020.
  • 277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on AUA Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.